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Abstracts: Glucocorticoid (GC) plays an important role in anti-inflammatory, anti-allergic effects and
immunosuppression, and has become a widely used drug in clinical departments. However, GC also produces a 
number of serious side effects at the same time. After GC acting on human body, the syndrome change has some 
regular pattern and it can be treated on the basis of syndrome differentiation and stage to aim at further improving 
therapeutic efficacy. The Chinese medicine can reduce the side effects of GC when treating the primary disease, 
thus plays a role in Synergism and Detoxification. 
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Glucocorticoid (GC) plays an important role in anti- 
inflammatory, anti-allergic effects and immun- 
osuppression, and can control a number of critical or 
intractable illness seizures. However, it often causes 
long-term dependence in treating chronic diseases, 
especially vulnerable to those who take it for a long time 
orally in which hypothalamic-pituitary-adrenal-thymus 
(HPAT) axis is inhibited, and then the reserve capacity of 
pituitary and adrenal cortex declines. A sudden stop or 
rapid decrement of GC will result in disease recurrence, 
even a crisis. Certain regularity could be found in terms 
of clinical manifestations, symptoms and signs of 
patients treated with GC. Therefore, to study the law of 
GC effect on changes of human body and choose the 
corresponding Chinese medicine in treatment will not 
only enhance the effectiveness of treatment, but also 
reduce the incidence of GC adverse reactions. 
Understanding of GC in Traditional Chinese 
Medicine 
1. The nature, flavor and attributive channel of GC
It is explained in TCM that the nature of GC pertains to 
pure yang.1 Under physiological conditions, stress state, 
and in small dosage substitution therapy, it is a medicine 
of pure yang. However, its pharmacologic and adverse 
actions, such as anti-inflammatory, immune suppression, 
negative nitrogen balance, etc. pertain to yin. So 
according to the principle to decide the nature of a 
medicine, it is cold in property, bitter in flavor and acts 
on the kidney meridian.2 It is also held that GC has 
physiological effects of physical fire (ᇥ☿) and side 
effects of evil fire (ໂ☿).  
2. The efficacy and indications of GC3 
Reinforcing fire and strengthening yang, warming and 
nourishing spleen and kidney: for adrenocortical 
hypofunction. Elevating kidney yang, reviving yang for 
resuscitation: for collapse of yin and yang, or depletion 
of qi syndrome. Mobilizing kidney yin and water to fight 
fire: for the syndrome of Yingfen (nutrient system㧹ߚ), 
Xuefen (blood system㸔ߚ) and pericardium invaded by 
heat-toxicity. Warming the spleen to resolve dampness: 
for edema caused by yang deficiency of the spleen and 
kidney. Dispelling wind and relieving itching: for eczema, 
asthma, purpura, etc. caused by pathogenic wind. 
Regulating qi-blood and yin-yang: for fever, limb pain, 
myasthenia, etc. caused by pathogenic wind, damp and 
heat, qi-blood and yin-yang imbalance.
The Influence of GC on Syndrome 
Syndrome is a reflection of the nature of a disease in a 
certain stage, which reflects the pathogenic factors and 
the state of the body response to them, and summarizes 
the pathology essence in the current stage of a disease, 
including the location, pathogenic factors, nature, and 
development of a disease, etc.4 Therefore, the influence 
of GC on syndrome is a reflection of the nature of both 
therapeutic and side effects on human body. 
Luo, et al.5 observed and analyzed the changes of TCM 
symptoms and signs and TCM differential types of 220 
adult patients with idiopathic nephrotic syndrome treated 
with prednisone. The prednisone application was in three 
levels, large, small and maintaining dosage. In studying 
the primary symptoms, it was found that 12% of the 
patients were of yin deficiency type, 58% of yang 
deficiency, and the remaining 30% of yin-yang 
deficiency. However, when different dosages were used, 
these figures changed to 73%, 9%, and 19% respectively 
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with large dosage of prednisone, and to 50%, 10%, and 
40% respectively after they took small dosage of 
prednisone, and to 16%, 26%, and 46% after taking a 
maintaining dosage. Meanwhile, in studying the 
incidental symptoms, it was found that the patients with 
toxic heat and damp heat went up obviously from 15% to 
61% and 13% to 49% respectively after they took a large 
dosage, then to 35% and to 45% after taking small 
dosage. During the entire course of prednisone treatment, 
changes in patients of accumulated fluid damp type 
reduced evidently compared to that of blood stasis and 
qi-stagnation types. These changes are closely related to 
the dosage of prednisone. So, a correct syndrome 
differentiation is helpful to improve the therapeutic effect 
of prednisone and can reduce adverse reactions. 
Wang, et al.6 indicated that in the prednisone application 
process, regardless of external symptoms and signs, the 
inherent essence at early stage is yin deficiency caused 
by internal heat according to experimental observation. 
Symptoms of adrenocortical hyperfunction in the stage 
of high-dose prednisone were differentiated as 
hyperactivity of fire due to yin deficiency syndrome
based on syndrome differentiation, while in prednisone 
withdrawal or stopping stage, symptoms of adrenal 
dysfunction were differentiated as a kidney-yang 
deficiency syndrome. Many scholars believed that the 
long-term or large-scale use of prednisone could cause 
blood stasis, kidney deficiency and consumption of 
anti-pathogenic qi.  
Synergism of TCM to GC 
1. High dose GC period 
Ren, et al.7 treated 36 children with henoch-schonlein 
purpura nephritis by randomly assigning them to two 
groups, the control group (18 cases) was treated with GC, 
the treated group (18 cases), besides the GC treatment, 
Zidian Shenning Decoction (㋿ⰰ㚒ᅕᮍ) was given 
additionally. GC was taken orally in 1.0–1.5 mg/kg per 
day for 8 weeks. Zidian Shenning Decoction mainly 
consists of Shui Niu Jiao (Cornu Bubali ), Sheng Di 
(Radix Rehmanniae), Chi Shao (Radix Paeoniae Rubra), 
Dan Pi (Cortex Moutan), Huang Qi (Radix Astragali), Zi 
Cao (Radix Arnebiae ), Yi Mu Cao (Herba Leonuri), 
Chan Tui (Periostracum Cicadae), Nü Zhen Zi (Fructus 
Ligustri Lucidi), etc. After 8 weeks treatment, 24 h urine 
protein and 12 h urine red blood cell count of both 
groups decreased significantly compared with pre- 
treatment (P<0.05), and the treated group did more 
significantly compared with the control group (P<0.05). 
Danshen Zhusheye (Ѝখ⊼ᇘ⎆ Salviac Miltiorrhizae 
Injection)8 and high-dose methylprednisolone were used 
in the treatment of nephritic syndrome. Thirty patients in 
the combined treatment group received Salviac 
Miltiorrhizae Injection and high-dose methy- 
lprednisolone, serum creatinine and urea nitrogen 
markedly decreased (P<0.05), but serum albumin 
increased significantly (P<0.05), compared with 
high-dose methylprednisolone randomly control group
(30 cases). Gu, et al.9 used Zishenqing Decoction (㞾䑿
⏙), consisting of Sheng Di (Radix Rehmanniae), Huang 
Qi (Radix Astragali), Bai Zhu (Rhizoma Atractylodis 
Macrocephalae), Gan Cao (Radix Et Rhizoma 
Glycyrrhizae), Bai Hua She She Cao (Herba Hedyotidis 
Diffusae), Dan Pi (Cortex Moutan), Chong Lou 
(Rhizoma Parudis), etc., to intervene 30 patients with 
active erythematosus (SLE). The other 30 patients were 
randomly assigned to the control group in the treatment 
of GC only. The dosage of GC in the treatment group 
kept decreasing and was significantly lower than that in 
the control group, moreover, the proportion of yin 
deficiency type and toxic heat type markedly reduced. 
Therefore, using heat-clearing, blood-cooling and yin 
nourishing Chinese medicine in high dose GC period can 
alleviate the symptoms, improve the therapeutic effect, 
and create conditions for further reduction of the GC 
dosage of later period. 
2. GC withdrawal period
Fan, et al.10 made a randomized controlled trial on 147 
patients with systemic lupus SLE. The control group (68 
cases) was treated mainly with prednisone only, while 
the integrated traditional Chinese and western medicine 
(ITCWM) group (79 cases) with Jiedu Quyu Ziyin (the 
method of removing toxic factors and blood stasis, and 
nourishing yin 㾷↦⼯⯔⒟䰈⊩ ) on the basis of 
prednisone. Both groups were treated for 2 courses, 3 
months as a therapy course. After 6 months, the trial 
showed that the prednisone dosage of the ITCWM group 
was lower than that in the control group with significant 
difference (P<0.05), and the total prednisone dosage in 
the ITCWM group was markedly lower than that in the 
control group (P<0.01). The ratio of cases who had to 
add prednisone for aggravation of disease in the ITCWM 
group (5.06%) was less than that in the control group 
(13.24%) significantly (P<0.05). The levels of 
adreno-cortico-tropic-hormone (ACTH) and Cortisol (CS) 
in the ITCWM group were significantly better than those 
in the control group (P<0.05). Similar results were 
obtained by Jin, et al.,11 who used Ziyin Langchuang 
Jiaonang (⒟䰈⣐⮂㛊ಞ Capsule for Systemic Lupus 
Erythematosus by Nourishing Yin ) to treat SLE in GC 
withdrawal period. 
Liu, et al.12 classified 24 patients with SLE into four 
syndrome types, i.e. the excessive noxious heat-qi and 
blood vigorous heat type, the qi and yin deficiency- 
obstruction of blood circulation type, the deficiency of 
spleen and kidney-stagnation of qi and blood stasis type, 
and the spleen deficiency and liver stagnation-blockage 
of channel type. He treated patients respectively with his 
self-formulated decoction by syndrome differentiation. 
Compared with the randomly controlled group (23 cases) 
which get the treatment of GC only, the general efficacy 
of the treated group was significantly better (P<0.05), 
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and the prednisone dosage of it decreased markedly 
(P<0.01). 
In GC withdrawal period, Chinese medicine can speed 
up GC withdrawal, and reduce the maintenance dose and 
the total dose, to reduce the side effects caused by GC. 
3. GC maintaining dosage period 
Guo, et al.13 used the empirical TCM recipe Yiqi Yangyin 
Decoction (Ⲟ⇨ݏ䰈∸Supplement Qi and Nourish Yin), 
consisting of Mai Dong (Radix Ophiopogonis ), Wu Wei 
Zi (Fructus Schisandrae Chinensis), Tai Zi Shen (Radix 
Pseudoxtellariae), Huang Qi (Radix Astragali), Dang Gui 
(Radix Angelicae Sinensis), Shan Yu Rou (Fructus 
Corni), Huai Shan Yao (Rhizoma Dioscoreae), Huang 
Jing (Rhizoma Polygonatum), Shu Di Huang (Prepared 
Radix Rehmanniae), Qin Jiao (Radix Gentianae 
Macrophyllae), Ban Zhi Lian (Herba Scutellariae 
Barbatae), etc., to treat 30 patients with SLE in remission 
stage. They also enrolled 10 patients treated by simple 
western medicine as control. The result showed that the 
Decoction could increase the total effective rate 
considerably, and decrease the maintaining dose of 
prednisone significantly, in comparison with the control 
group (P<0.05). Moreover, the immune parameters (IgG 
and C3) were significantly improved after treatment in 
the treatment group (P<0.01).
Wenshen No. I (⏽㚒 Iো Kidney Warming No.I) was 
used to treat steroid-dependent refractory nephrotic 
syndrome. It mainly consists of Huang Qi (Radix 
Astragali), Xian Ling Pi (Herba Epimedii), Lu Jiao Jiao 
(Colla Cornus Cervi), Zi He Che Fen (Placenta Hominis 
Power), Tu Si Zi (Semen Cuscutae), Dang Gui (Radix 
Angelicae Sinensis), Dan Shen (Radix Salviae 
Miltiorrhizae), Di Long (Lumbricus), etc. The clinical 
study by Pan, et al.14 illustrated that combination of 
Wenshen No. I and Western medicine could be more 
effective in lowering 24 h urine protein, serum creatinine 
and urea nitrogen (P<0.05), and increasing serum total 
protein and albumin (P<0.05) than in the randomly 
control western medicine group. Yi, et al.15 also acquired 
similar effect in treating refractory nephrotic syndrome 
with Huoba Huagen Pian (☿ᡞ㢅ḍ⠛ Colquhounia 
Root Tablet). 
In GC maintaining dosage period, Chinese medicine can 
improve biochemistry index and then further increase 
therapeutic effect. 
4. Others 
Kou, et al.16 did Meta-analysis on efficacy of 
tripterygium glycosides (TG) and GC for nephritic 
syndrome. The results showed that TG combined with 
GC had good effects in reducing the recurrence. Clinical 
observation on 60 SLE patients carried out by Yang, et 
al.,17118 patients by Chen, et al.18 and 52 patients by 
Zhang, et al.19 all showed that the improvement rate in 
yin deficiency and fire excess syndrome marked by the 
symptoms of hair loss, hypodynamia, vexation, nausea 
and vomiting, edema, abnormal menstruation, and the 
complaints of dental ulcer, lassitude, insomnia, was 
higher than that in the control group or before the 
Chinese medicine treatment respectively (P<0.05 or 
P<0.01).  
Wen, et al.20 did researches on the quality of life (QOF) 
of the patients with SLE by short form-36 (SF-36), 
before and after they were treated by TCM Jiedu Quyu 
Ziyin method. The control group (68 cases) was treated 
mainly with prednisone only, while the ITCWM group 
(79 cases) with TCM Jiedu Quyu Ziyin method on the 
basis of prednisone. After 6-month treatment, the 
ITCWM group had better effect than the control group 
on the QOF. 
Detoxification of TCM to GC
1. Effects on bone metabolism 
Chen, et al.21 used Bugu Capsule (㸹偼㛊ಞ Capsule for 
Strengthening the Bone ) consisting of Yin Yang Huo
(Herba Epimedii), Huang Qi (Radix Astragali), Bai Zhu 
(Rhizoma Atractylodis Macrocephalae), etc. to treat 34 
patients with SLE in the treatment of GC, and also 
enrolled 32 patients as the control. The course of 
treatment was 6–18 months. The incidence of 
osteoporosis or osteopenia in treated group (2 cases) was 
decreased significantly (P<0.05), compared with the 
control group (9 cases). Fan, et al.22 controlled 
GC-induced osteoporosis in SLE with Jiedu Quyu 
Ziyinmethods. The control group (68 cases) treated 
mainly with prednisone only, while the ITCWM group 
(79 cases) with Jiedu Quyu Ziyin method on the basis of 
prednisone. Both groups were treated for 6 months. The 
levels of serum P, 25-(OH) D3, alkaline phosphatase 
(ALP), serum bone gla protein (BGP) and bone mineral 
density (BMD) in the ITCWM group were significantly 
higher than those in the control group (P<0.05), and the 
lever of urinary calcium and parathyroid hormone (PTH) 
were also lower obviously (P<0.05). 
2. Effects on lipid metabolism and hemorheology 
Xuezhikang (㸔㛖ᒋ Capsule for Lipid),23 a Chinese 
medicine preparation made from extract of a specially 
made Red Koji (㑶᳆) after the fermentation with its 
active ingredient lovastatin and a variety of lipid- 
lowering composition, can generally adjust the lipid 
spectrum, and may exist beyond the protective effect of 
lipid. Yang, et al.24 used Xuezhikang capsule to treat the 
patients of nephrotic syndrome with hyperlipidemia, who 
were randomly divided into Xuezhikang group (19 cases) 
and simvastatin group (18 cases). The level of TC, TG 
and LDL-C were lower obviously (P<0.01), and the level 
of TP, ALB and HDL-C significantly increased (P<0.01 
or <0.05) in both groups, and no significant differences 
were found in both groups before and after the treatment 
(P>0.05). The result of the study conducted by Wang, et 
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al.25 also concluded that Jiedu Quyu Ziyin methods could 
prevent and cure corticosteroid hyperlipemia of SLE. 
The randomized controlled clinical trial by Wu, et al.26 
displayed that the total effective rate (88.7%) of GC and 
Western medicine supportive treatment combined with 
Shuizhi Zhushe Injection (∈㳁⊼ᇘ⎆ Injection of 
Leech) in treating primary nephrotic syndrome was 
better than that (70.4%) of Western medicine alone 
(P<0.05) with significant difference between the two in 
aspects of the level of TC and TG, high and low shear 
rate and blood sedimentation rate (P<0.05 or P<0.01). 
The study by Nie, et al.27 showed that Xueshuantong (㸔
ᷧ 䗮 Thrombus Removal) and Dengzhan Xixin 
Zhusheye (♃ⲣ㒚䕯⊼ᇘ⎆ Injection of Herba 
Erigerontis) had the lipid-lowering and anticoagulative 
effects bringing no major adverse events in the treatment 
of nephrotic syndrome. Pan, et al.28 did researches on the 
regulation effect of Qize Decoction (㡾⋑∸ Decoction 
of Astragalus and Americanwater Plantain) on fibrinogen 
in the treatment of nephrotic syndrome with GC. Qize 
decoction consists of Mo Han Lian (Herba Ecliptae), Nü 
Zhen Zi (Fructus Ligustri Lucidi), Dan Shen (Radix 
Salviae Miltiorrhizae), Yi Mu Cao (Herba Leonuri), 
Huang Qi (Radix Astragali), Ze Xie (Rhizoma 
Alismatis ), Shui Zhi (Hirudo), Chuan Xiong (Rhizoma 
Chuanxiong), etc. The level of fibrinogen in the treated 
group decreased significantly (P<0.01), compared with 
that of the control group after 2-week treatment. 
Wen, et al.29 used the Chinese medicine Lang Chuang 
Ding (⣐⮂ᅮ LCD-Systemic Lupus Erythematosus 
Relieving), consisting of Bai Hua She She Cao (Herba 
Hedyotidis Diffusae), Chi Shao (Radix Paeoniae Rubra), 
Sheng Di (Radix Rehmanniae), Shui Niu Jiao (Cornu 
Bubali), Zi Cao (Radix Arnebiae), Sheng Ma (Rhizoma 
Cimicifugae ), Zhi Bie Jia (Prepared Turtle Shell), on the 
basis of GC treatment to improve microcirculation of 25 
patients with SLE, while the other 20 patients were 
selected randomly as a control group and treated with 
GC alone. It showed that the total scores of 
microcirculation including the shape of loops, blood flow 
speed, exudates and hemorrhage around the loops in the 
treated group were better than those of the control group 
(P<0.05) after 3-month treatment, which meant that LCD 
could effectively alleviate the microcirculation disorders 
of SLE and improve the therapeutic effect of GC on 
SLE. 
3. Others 
Total 100 patients of nephrotic syndrome were treated by 
Qiu, et al.30 They were randomly divided into two groups, 
the ITCWM treatment group (treatment group), and the 
control group. In GC inductive treatment stage, the 
treatment group was treated with nourishing yin and 
clearing away heat, cooling and activating blood, and the 
recipe consisted of Sheng Di (Radix Rehmanniae), Xuan 
Shen (Radix Scrophulariae), Mai Dong (Radix 
Ophiopogonis), Mo Han Lian (Herba Ecliptae), Nü Zhen 
Zi (Fructus Ligustri Lucidi), Chi Shao (Radix Paeoniae 
Rubra), Dan Pi (Cortex Moutan), etc, for 8 weeks. In GC 
decreasing stage, it was treated with tonifying both yin 
and yang, and the recipe consisted of Huang Qi (Radix 
Astragali), Tai Zi Shen (Radix Pseudostell), Tu Si Zi (㦳
Semen Cuscutae), Bai Zhu (Rhizoma Atractylodis 
Macrocephalae), Yin Yang Huo (Herba Epimedii), etc, 
for 6 months. In GC maintaining stage, it was treated 
with benefiting qi to consolidate kidney, strengthening 
spleen and activating blood, and the basic recipe was 
composed of Huang Qi (Radix Astragali), Bai Zhu 
(Rhizoma Atractylodis Macrocephalae), Ba Ji Tian 
(Radix Morindae Officinalis), Mo Han Lian (Herba 
Ecliptae), Dang Gui (Radix Angelicae Sinensis), Dan 
Shen (Radix Salviae Miltiorrhizae), Jin Ying Zi (Fructus 
Rosae Laevigatae), eta, for 12 months. The rate of 
adverse reactions such as cushing syndrome, infection, 
upper gastrointestinal bleeding, hypertension, osteo- 
porosis or femoral head necrosis, etc of the treatment 
group was significantly lower than that of the control 
group (P<0.01). The study by Zhang, et al.31 showed that 
compared with the simple Western medicinal treatment 
of SLE, Āmodified Zibai Dihuang Decoction (ࡴੇⶹᶣ
ഄ 咘 ∸ Modified Decoction of Anemarrhena, 
Phellodendron and Rehmannia) combined with Western 
medicine showed significant difference in reducing the 
occurrence of Cushing’s syndrome. 
Tao, et al.32 treated 110 SLE patients who were randomly 
assigned to 2 groups equally, the control group treated 
with the conventional Western medicinal treatment and 
the treated group treated with the same treatment and 
SLE I formula (in active stage) or SLE II formula (in 
silent period) respectively. In active stage, it was treated 
with the method of heat-clearing and detoxifying, and 
SLE I formula consisted of Sang Bai Pi (Cortex mori), 
Di Gu Pi (Cortex Lycii Chinensis ), Gan Cao (Radix Et 
Rhizoma Glycyrrhizae), Bai Shao (Radix Paeoniae Alba), 
Xuan Shen (Radix Scrophulariae), Qing Hao (Artemisia), 
Zhi Mu (anemarrhena). In silent period, it was treated 
with the method of nourishing yin and moistening the 
lung, and SLE II formula consisted of Bai He (Lilium), 
Tian Dong (Asparagus Root), Mai Dong (Radix 
Ophiopogonis), Bai Shao (Radix Paeoniae Alba), Dang 
Gui (Radix Angelicae Sinensis), Xuan Shen (Radix 
Scrophulariae), Bei Mu (Fritillaria), Jie Geng (Radix 
Platycodonis), Gan Cao (Radix Et Rhizoma 
Glycyrrhizae), Dan Zhu Ye (Herba Lophatheri). The 
incidence of complicated infection and antibiotic 
utilization rate in the 2-year treatment was 23.6%, 55.0% 
respectively in the treated groupˈmarkedly lower than 
those (50.9% and 100%) in the control group 
respectively (P<0.01), which meant TCM treatment 
focusing on the lung could decrease the incidence of 
complicated infection and the antibiotic utilization rate in 
SLE patients. It has also been proved by the study by Tao, 
et al.33 that besides the above mentioned superiorities, 
Chinese medicine could regulate T lymphocyte subsets 
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of the patients with SLE, especially increase CD4+ T 
lymphocyte subset, and improve the body's anti-infection 
ability. 
Evaluation and Prospect 
Chinese medicines have obtained confirmative efficacies 
in the treatment of various diseases with GC. Clinical 
and experimental studies on the synergy and attenuation 
of Chinese medicine have provided powerful evidences 
for the clinical application of Chinese medicine. The 
essence of TCM is “Treatment of diseases based on 
syndrome differentiation”. According to clinical 
symptoms during GC application, we can treat the 
primary disease based on syndrome differentiation, and 
at the same time reduce the side effects of GC, which can 
complement each other. Now, the researches are mainly 
focused on the clinical studies of compound Chinese 
medicine rather than the effective components and 
mechanism. Therefore, to clarify the efficacy of Chinese 
medicine, future research should be made to develop the 
multiple-center, large-sample randomized control trials, 
and carried out studies on the effective components and 
mechanism of compound Chinese medicine. In 
conclusion, Synergism and Detoxification of Chinese 
Medicine for GC can not only improve the efficacy, but 
also reduce the side effects of GC, therefore, the study of 
Chinese medicine is of great significance. 
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